Literature DB >> 8791288

Ultrastructural analysis of mineralized matrix from human osteoblastic cells: effect of tumor necrosis factor-alpha.

F S Panagakos1, C Fernandez, S Kumar.   

Abstract

Recent work by a number of investigators has demonstrated that the process of bone matrix formation and mineralization is under the influence of growth factors and cytokines present in the local environment. Utilizing primary and established osteoblast cell culture systems, these studies have examined the regulation of bone matrix protein synthesis and deposition into the extracellular matrix (ECM) and subsequent mineralization. In previous studies, we have utilized the human osteoblastic cell line, HOS TE85, to study the effects of Tumor Necrosis Factor-alpha (TNF-alpha) on the regulation of matrix proteins and proteolytic function in monolayer cultures as well as during the development and calcification of ECM formed by HOS TE85 cells during extended culture. Our studies demonstrate that TNF-alpha inhibited formation and mineralization of nodules. In the study reported here, we evaluated the ultrastructural morphology of the cell-matrix complex formed by HOS TE85 cells in the presence and absence of TNF-alpha at selected time points during the matrix development process utilizing both transmission electron microscopy and light microscopy. In the presence of TNF-alpha, the cell-matrix complex does not develop normally, with a lack of organization and mineralization, when compared to untreated cells. The lack of mineralization appears to result from the lack of normal collagen fibril deposition and formation of an appropriate ECM essential for the mineralization process. These results support our previous observations that TNF-alpha inhibits HOS TE85 cells from forming a mineralizing ECM by inhibiting incorporation of collagen into the ECM and inducing the synthesis of proteolytic enzymes capable of degrading collagen in the ECM.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8791288     DOI: 10.1007/bf00225886

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

1.  Effect of immune cytokines on bone.

Authors:  P Stashenko; M S Obernesser; F E Dewhirst
Journal:  Immunol Invest       Date:  1989 Jan-May       Impact factor: 3.657

2.  Tumour necrosis factor alpha in gingival crevicular fluid as a possible indicator of periodontal disease in humans.

Authors:  E F Rossomando; J E Kennedy; J Hadjimichael
Journal:  Arch Oral Biol       Date:  1990       Impact factor: 2.633

Review 3.  Growth factors and the regulation of bone remodeling.

Authors:  E Canalis; T McCarthy; M Centrella
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

Review 4.  The role of inflammatory mediators in the pathogenesis of periodontal disease.

Authors:  R C Page
Journal:  J Periodontal Res       Date:  1991-05       Impact factor: 4.419

5.  Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes.

Authors:  V Lefebvre; C Peeters-Joris; G Vaes
Journal:  Biochim Biophys Acta       Date:  1990-05-22

6.  Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha.

Authors:  J M Alvaro-Gracia; N J Zvaifler; C B Brown; K Kaushansky; G S Firestein
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

7.  Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta.

Authors:  M R Duncan; B Berman
Journal:  J Invest Dermatol       Date:  1989-05       Impact factor: 8.551

8.  Effects of interleukin-1 beta and tumor necrosis factor-alpha on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro.

Authors:  R S Taichman; P V Hauschka
Journal:  Inflammation       Date:  1992-12       Impact factor: 4.092

9.  Effects of tumor necrosis factor alpha and beta on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes.

Authors:  I K Campbell; D S Piccoli; M J Roberts; K D Muirden; J A Hamilton
Journal:  Arthritis Rheum       Date:  1990-04

10.  Interleukin-1 beta is a potent inhibitor of bone formation in vitro.

Authors:  P Stashenko; F E Dewhirst; M L Rooney; L A Desjardins; J D Heeley
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

View more
  3 in total

Review 1.  The role of stromal cells in inflammatory bone loss.

Authors:  C Wehmeyer; T Pap; C D Buckley; A J Naylor
Journal:  Clin Exp Immunol       Date:  2017-05-18       Impact factor: 4.330

2.  A crucial role for thiol antioxidants in estrogen-deficiency bone loss.

Authors:  Jenny M Lean; Julie T Davies; Karen Fuller; Christopher J Jagger; Barrie Kirstein; Geoffrey A Partington; Zoë L Urry; Timothy J Chambers
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 3.  Osteoblast Role in Rheumatic Diseases.

Authors:  Addolorata Corrado; Nicola Maruotti; Francesco Paolo Cantatore
Journal:  Int J Mol Sci       Date:  2017-06-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.